LBH Phase II in Small Cell Lung Cancer (SCLC)

NCT01222936 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Small Cell Lung Carcinoma

Interventions

DRUG: LBH581

Sponsor

Southern Europe New Drug Organization

Collaborators

[object Object]